Pharmabiz

GSK & Spero announce positive PIVOT-PO phase III trial of tebipenem HBr, an investigational ...

GSK & Spero announce positive PIVOT-PO phase III trial of tebipenem HBr, an investigational oral treatment for complicated urinary tract infections: London, UK Wednesday, October ...
Pharmabiz

US FDA clears SINTX Technologies’ SINAPTIC Foot & Ankle implant system

US FDA clears SINTX Technologies’ SINAPTIC Foot & Ankle implant system: Salt Lake City, Utah Wednesday, October 22, 2025, 17:00 Hrs [IST] SINTX Technologies, Inc., a leader in a ...
Pharmabiz

EMA committee issues positive opinion to support the approval of GSK’s recombinant zoster ...

EMA committee issues positive opinion to support the approval of GSK’s recombinant zoster vaccine, Shingrix in a prefilled syringe: London, UK Wednesday, October 22, 2025, 16:00 ...
Pharmabiz

Healthium Medtech certified as a Great Place to Work for the fourth consecutive year

Healthium Medtech certified as a Great Place to Work for the fourth consecutive year: Our Bureau, Bengaluru Wednesday, October 22, 2025, 15:15 Hrs [IST] Healthium Medtech, a globa ...
Pharmabiz

Merck breaks ground on $3 billion Center of Excellence for Pharmaceutical Manufacturing in ...

Merck breaks ground on $3 billion Center of Excellence for Pharmaceutical Manufacturing in Elkton, Virginia: Rahway, New Jersey Wednesday, October 22, 2025, 15:00 Hrs [IST] Merck, ...
Pharmabiz

Superhealth and United Imaging ink Rs. 2,500 crore pact, the single-largest radiology ...

Our Bureau, Bengaluru Wednesday, October 22, 2025, 14:40 Hrs [IST] ...
Pharmabiz

Meenakshi Super Speciality Hospital receives LEED Platinum Certification from the US Green ...

Meenakshi Super Speciality Hospital receives LEED Platinum Certification from the US Green Building Council: Our Bureau, Mumbai Wednesday, October 22, 2025, 14:30 Hrs [IST] Meenak ...
Pharmabiz

Chugai Pharma & Rani Therapeutics ink agreement to develop and commercialize oral ...

Chugai Pharma & Rani Therapeutics ink agreement to develop and commercialize oral formulation leveraging RaniPill technology: Tokyo Wednesday, October 22, 2025, 12:00 Hrs [IST] Ch ...
Pharmabiz

Pfizer’s phase 2 PHAROS trial of Braftovi plus Mektovi shows sustained long-term survival ...

Pfizer’s phase 2 PHAROS trial of Braftovi plus Mektovi shows sustained long-term survival in patients with advanced lung cancer: New York Wednesday, October 22, 2025, 11:00 Hrs ...
Pharmabiz

Roche’s Gazyva/Gazyvaro receives US FDA approval for the treatment of lupus nephritis

Roche’s Gazyva/Gazyvaro receives US FDA approval for the treatment of lupus nephritis: Basel Wednesday, October 22, 2025, 10:00 Hrs [IST] Roche announced that the US Food and Dr ...
Pharmabiz

Sanofi’s high-dose influenza vaccine demonstrates superior protection for older adults ...

Sanofi’s high-dose influenza vaccine demonstrates superior protection for older adults against hospitalization vs standard-dose: Paris Wednesday, October 22, 2025, 09:00 Hrs [IS ...
Pharmabiz

Govt should mandate PG cos to supply small quantities 'as required' by MSMEs to halt ...

Govt should mandate PG cos to supply small quantities 'as required' by MSMEs to halt contamination: TN IDMA: Peethaambaran Kunnathoor, Chennai Wednesday, October 22, 2025, 08:00 H ...